Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors-Reference-Cited by-同舟云学术

Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors

Published:2020-11 Issue: Volume:104 Page:104260
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Al-Wahaibi Lamya H.,Gouda Ahmed M.,Abou-Ghadir Ola F.,Salem Ola I.A.,Ali Asmaa T.,Farghaly Hatem S.,Abdelrahman Mostafa H.,Trembleau Laurent,Abdu-Allah Hajjaj H.M.,Youssif Bahaa G.M.

Funder

Deanship of Scientific Research

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference46 articles.

1. Kinase-targeted cancer therapies: progress, challenges and future directions;Bhullar;Mol. Cancer,2018

2. Protein kinases-the major drug targets of the twenty-first century?;Cohen;Nat. Rev. Drug Discov.,2002

3. Dual-target kinase drug design: Current strategies and future directions in cancer therapy;Sun;European J. Med. Chem.,2020

4. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity;Anastassiadis;Nat. Biotechnol.,2011

5. Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms;Hughes;Nat. Rev. Genet.,2015

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A concise review on recent development of indole derivatives for anticancer activities;Journal of the Indian Chemical Society;2024-10

2. Design and synthesis new indole-based aromatase/iNOS inhibitors with apoptotic antiproliferative activity;Frontiers in Chemistry;2024-09-06

3. Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors;Frontiers in Chemistry;2024-08-30

4. Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors;ACS Omega;2024-08-01

5. Design, synthesis, and antiproliferative activity of new indole/1,2,4‐triazole/chalcone hybrids as EGFR and/or c‐MET inhibitors;Archiv der Pharmazie;2024-06-21